Protein shedding in urothelial bladder cancer: prognostic implications of soluble urinary EGFR and EpCAM

BACKGROUND: Better biomarkers must be found to develop clinically useful urine tests for bladder cancer. Proteomics can be used to identify the proteins released by cancer cell lines and generate candidate markers for developing such tests. METHODS: We used shotgun proteomics to identify proteins re...

Descripción completa

Detalles Bibliográficos
Autores principales: Bryan, R T, Regan, H L, Pirrie, S J, Devall, A J, Cheng, K K, Zeegers, M P, James, N D, Knowles, M A, Ward, D G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2015
Materias:
Molecular Diagnostics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4366887/
https://www.ncbi.nlm.nih.gov/pubmed/25719831
http://dx.doi.org/10.1038/bjc.2015.21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4366887/
https://www.ncbi.nlm.nih.gov/pubmed/25719831
http://dx.doi.org/10.1038/bjc.2015.21

Ejemplares similares